These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1384642)

  • 1. Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice.
    Andrade SP; Bakhle YS; Hart I; Piper PJ
    Br J Cancer; 1992 Nov; 66(5):821-6. PubMed ID: 1384642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse.
    Andrade SP; Vieira LB; Bakhle YS; Piper PJ
    Int J Exp Pathol; 1992 Aug; 73(4):503-13. PubMed ID: 1382541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological reactivity of neoplastic and non-neoplastic associated neovasculature to vasoconstrictors.
    Andrade SP; Beraldo WT
    Int J Exp Pathol; 1998 Dec; 79(6):425-32. PubMed ID: 10319023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet activating factor (PAF) on the formation of blood vessels in subcutaneous implants in mice.
    Andrade SP; Vieira LB; Bakhle YS; Piper PJ
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):117-21. PubMed ID: 7516807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
    Andrade SP; Hart IR; Piper PJ
    Br J Pharmacol; 1992 Dec; 107(4):1092-5. PubMed ID: 1281718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model.
    Hu DE; Hiley CR; Fan TP
    Br J Pharmacol; 1996 Feb; 117(3):545-551. PubMed ID: 8821547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers.
    Hu DE; Hiley CR; Smither RL; Gresham GA; Fan TP
    Lab Invest; 1995 May; 72(5):601-10. PubMed ID: 7538184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of flavone acetic acid on established versus developing tumour blood flow.
    Mahadevan V; Hart IR
    Br J Cancer; 1991 Jun; 63(6):889-92. PubMed ID: 1712621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO).
    Ferreira MA; Barcelos LS; Campos PP; Vasconcelos AC; Teixeira MM; Andrade SP
    Br J Pharmacol; 2004 Apr; 141(7):1185-92. PubMed ID: 15023865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-II-induced angiogenesis in sponge implants in mice.
    Andrade SP; Cardoso CC; Machado RD; Beraldo WT
    Int J Microcirc Clin Exp; 1996; 16(6):302-7. PubMed ID: 9049708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.
    Hori Y; Hu DE; Yasui K; Smither RL; Gresham GA; Fan TP
    Br J Pharmacol; 1996 Aug; 118(7):1584-91. PubMed ID: 8842418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple therapy with octreotide, galanin, and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma.
    El-Salhy M; Sitohy B; Norrgård O
    Regul Pept; 2003 Mar; 111(1-3):145-52. PubMed ID: 12609762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative in-vivo studies on angiogenesis in a rat sponge model.
    Andrade SP; Fan TP; Lewis GP
    Br J Exp Pathol; 1987 Dec; 68(6):755-66. PubMed ID: 2447929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery.
    De Meyer GR; Bult H; Ustünes L; Kockx M; Jordaens FH; Zonnekeyn LL; Herman AG
    Br J Pharmacol; 1994 Jun; 112(2):471-6. PubMed ID: 7521257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cells regulate the angiogenic switch during tumorigenesis.
    Okamoto R; Ueno M; Yamada Y; Takahashi N; Sano H; Suda T; Takakura N
    Blood; 2005 Apr; 105(7):2757-63. PubMed ID: 15572584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of tumour blood flow.
    Jirtle RL
    Int J Hyperthermia; 1988; 4(4):355-71. PubMed ID: 3290350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and metastasis of human tumors in nude mice following tumor-cell inoculation into a vascularized polyurethane sponge matrix.
    Thiede K; Momburg F; Zangemeister U; Schlag P; Schirrmacher V
    Int J Cancer; 1988 Dec; 42(6):939-45. PubMed ID: 3192337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.
    Leunig M; Yuan F; Menger MD; Boucher Y; Goetz AE; Messmer K; Jain RK
    Cancer Res; 1992 Dec; 52(23):6553-60. PubMed ID: 1384965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic activity of PAF and inhibition of blood flow by Bothrops Jararaca venom in a mouse sponge model.
    Vieira LB; Rodrigues JA; Leite VH; Andrade SP
    EXS; 1992; 61():302-7. PubMed ID: 1377548
    [No Abstract]   [Full Text] [Related]  

  • 20. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis.
    Ogawa H; Nishihira J; Sato Y; Kondo M; Takahashi N; Oshima T; Todo S
    Cytokine; 2000 Apr; 12(4):309-14. PubMed ID: 10805210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.